171 related articles for article (PubMed ID: 11350408)
21. Bcl-2 overexpression results in reciprocal downregulation of Bcl-X(L) and sensitizes human testicular germ cell tumours to chemotherapy-induced apoptosis.
Arriola EL; Rodriguez-Lopez AM; Hickman JA; Chresta CM
Oncogene; 1999 Feb; 18(7):1457-64. PubMed ID: 10050882
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant therapy for stage I testicular cancer.
Cullen M; James N
Cancer Treat Rev; 1996 Jul; 22(4):253-64. PubMed ID: 9025783
[No Abstract] [Full Text] [Related]
23. Drug dose delivery and treatment outcome relationship in standard bleomycin, etoposide and cisplatin combination chemotherapy in nonseminomatous germ cell tumor patients.
Gutierrez-Delgado F; Titov DA; Tjulandin SA; Garin AM
Neoplasma; 1999; 46(3):190-5. PubMed ID: 10613596
[TBL] [Abstract][Full Text] [Related]
24. [Management of stage I testicular nonseminomatous germ cell tumors with an embryonic carcinomatous component. 18 cases].
Drianno N; Robert M; Legouffe E; Guiter J; Navratil H
Prog Urol; 1997 Sep; 7(4):622-7. PubMed ID: 9410322
[TBL] [Abstract][Full Text] [Related]
25. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
26. Outcome analysis after post-chemotherapy surgery in patients with non-seminomatous germ cell tumours.
Gerl A; Clemm C; Schmeller N; Dienemann H; Lamerz R; Kriegmair M; Wilmanns W
Ann Oncol; 1995 May; 6(5):483-8. PubMed ID: 7545430
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment.
Mayer F; Gillis AJ; Dinjens W; Oosterhuis JW; Bokemeyer C; Looijenga LH
Cancer Res; 2002 May; 62(10):2758-60. PubMed ID: 12019150
[TBL] [Abstract][Full Text] [Related]
28. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.
Ondrus D; Hornák M; Breza J; Mat'oska J; Schnorrer M; Belan V; Kausitz J
Int Urol Nephrol; 2001; 32(4):665-7. PubMed ID: 11989561
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy of disseminated germ cell tumors.
Nichols CR
Semin Urol Oncol; 2001 Aug; 19(3):157-64. PubMed ID: 11561982
[TBL] [Abstract][Full Text] [Related]
30. Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy.
Pectasides D; Pectasides M; Farmakis D; Nikolaou M; Koumpou M; Kostopoulou V; Mylonakis N
Eur Urol; 2004 Feb; 45(2):187-93. PubMed ID: 14734005
[TBL] [Abstract][Full Text] [Related]
31. [Chemotherapy for metastatic germ cell tumours of the testis].
Culine S
Rev Prat; 2007 Feb; 57(4):385-8. PubMed ID: 17455740
[TBL] [Abstract][Full Text] [Related]
32. [Primary diffuse large B-cell lymphoma of testis: a clinicopathologic study of 14 cases].
Li D; Mi C; Zhao Y; Wang YL; Ma Y; Li YY; Xiang MH
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):461-5. PubMed ID: 17845759
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of P53, BCL-2, and BAX in advanced head and neck carcinoma.
Casado S; Forteza J; Dominguez S; Abad MT; Perez I; Intxaurbe I; del Campo JM; Lopez R
Am J Clin Oncol; 2002 Dec; 25(6):588-90. PubMed ID: 12478005
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
35. Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.
Burger H; Nooter K; Boersma AW; Kortland CJ; Stoter G
Br J Cancer; 1998 May; 77(10):1562-7. PubMed ID: 9635829
[TBL] [Abstract][Full Text] [Related]
36. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
[TBL] [Abstract][Full Text] [Related]
37. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation.
Trask DK; Wolf GT; Bradford CR; Fisher SG; Devaney K; Johnson M; Singleton T; Wicha M
Laryngoscope; 2002 Apr; 112(4):638-44. PubMed ID: 12150516
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy for testicular cancer.
Xiao H; Sheinfeld J; Motzer RJ
Surg Oncol Clin N Am; 1997 Oct; 6(4):863-78. PubMed ID: 9309098
[TBL] [Abstract][Full Text] [Related]
39. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
40. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.
Geldart TR; Gale J; McKendrick J; Kirby J; Mead G
BJU Int; 2006 Aug; 98(2):353-8. PubMed ID: 16879677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
